Plain-English translation of NCT06857669 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing two new ways to examine breast tissue using light-based imaging instead of traditional methods like mammography or MRI. One technique, called diffuse reflectance spectroscopy, uses white light to analyze tissue properties. The other, photoacoustic imaging, combines light with ultrasound to create detailed images and measure oxygen levels in tissue — which differs between healthy and cancerous breast tissue. These tests could one day offer a safer, more comfortable alternative to current breast cancer diagnostic tools.
Current breast cancer imaging methods have drawbacks: mammograms expose you to radiation, MRI often requires contrast dye injected into your veins, and diagnosis frequently requires painful biopsies. This trial is exploring whether these new light-based techniques could provide accurate diagnosis without radiation, without injected dyes, and without invasive procedures.
You likely qualify if…
You likely don't qualify if…
Depending on which study phase you join, you may have breast tissue samples examined in a laboratory using the new imaging techniques, or you may visit a clinic for an in-vivo scan (imaging performed directly on your body). The study involves three phases with 30 participants each: some will undergo one light-based test, others will undergo two different light-based tests, and a final group will have imaging performed on living breast tissue. The procedures are non-invasive and designed to be comfortable and quick.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Sweden
Sponsor
Region Skane
Collaborators
Lund University, Unilabs
Enrollment target
~90 participants
Started
December 2020
Primary completion
December 2026
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sophia Zackrisson, MD, PhD
Region Skane, Lund University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.